Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Alamar Biosciences, Inc.NASDAQ: ALMR

Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026

Stock-based compensation of $0 in Q2 FY2026

Q2 FY2026 stock-based compensation was $0.

Context

  • Stock-based compensation amounted to 3.9% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$2.87M— YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
2.87M USD
Year-over-year change
—

Stock-Based Compensation vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 stock-based compensation of $2.87M is the smallest of the 9 companies compared; the peer median is $20.18M.
  • Stock-based compensation amounts to 3.9% of revenue for ALMR, versus a peer median of 16.0%.
ALMR Competitors Peer median
Stock-Based Compensation for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TXG10x Genomics, Inc.LTM Jun 2026$98.74M -20.9%-7.3%16.0%
TWSTTwist Bioscience CorporationLTM Sep 2026$69.86M +8.4%+32.1%15.2%
TECHBio-Techne CorporationLTM Sep 2026$43.09M +56.0%+1.8%3.5%
LABStandard BioTools Inc.LTM Mar 2026$27.48M -5.7%+25.8%31.9%
SEERSeer, Inc.LTM Mar 2026$12.88M -49.1%-22.9%85.6%
QSIQuantum-Si incorporatedLTM Mar 2026$10.98M +14.3%-1.3%592.7%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$9.59M -84.2%-19.1%6.0%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$6.04M -48.6%-13.0%—
ALMRAlamar Biosciences, Inc.FY2025$2.87M ——3.9%
Peer median (excluding ALMR) $20.18M-13.3%-4.3%16.0%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.